115 related articles for article (PubMed ID: 8729977)
1. 17 beta-hydroxysteroid dehydrogenase in common epithelial ovarian tumors.
Sasano H; Suzuki T; Niikura H; Kaga K; Sato S; Yajima A; Rainey WE; Nagura H
Mod Pathol; 1996 Apr; 9(4):386-91. PubMed ID: 8729977
[TBL] [Abstract][Full Text] [Related]
2. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
3. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
[TBL] [Abstract][Full Text] [Related]
4. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
[TBL] [Abstract][Full Text] [Related]
5. Type 2 11beta-hydroxysteroid dehydrogenase activity in human ovarian cancer.
Temkin S; Nacharaju VL; Hellman M; Lee YC; Abulafia O
Steroids; 2006 Nov; 71(11-12):1019-23. PubMed ID: 17028049
[TBL] [Abstract][Full Text] [Related]
6. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.
Autio-Harmainen H; Karttunen T; Hurskainen T; Höyhtyä M; Kauppila A; Tryggvason K
Lab Invest; 1993 Sep; 69(3):312-21. PubMed ID: 8377473
[TBL] [Abstract][Full Text] [Related]
7. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
8. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
Huang LW; Garrett AP; Bell DA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Jun; 77(3):369-76. PubMed ID: 10831344
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.
Moore DH; Michael H; Tritt R; Parsons SH; Kelley MR
Clin Cancer Res; 2000 Feb; 6(2):602-9. PubMed ID: 10690545
[TBL] [Abstract][Full Text] [Related]
11. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary.
Bruening W; Giasson BI; Klein-Szanto AJ; Lee VM; Trojanowski JQ; Godwin AK
Cancer; 2000 May; 88(9):2154-63. PubMed ID: 10813729
[TBL] [Abstract][Full Text] [Related]
12. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
[TBL] [Abstract][Full Text] [Related]
13. u-PA expression in benign, borderline and malignant ovarian tumors.
Kiziridou AD; Toliou T; Stefanou D; Agnantis N
Anticancer Res; 2002; 22(2A):985-90. PubMed ID: 12014682
[TBL] [Abstract][Full Text] [Related]
14. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
15. Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies.
van Niekerk CC; Vooijs P; Casparie-van Velsen IJ; Poels LG
Cancer Detect Prev; 1997; 21(3):247-57. PubMed ID: 9167042
[TBL] [Abstract][Full Text] [Related]
16. The analyses of 17beta-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma.
Utsunomiya H; Suzuki T; Kaneko C; Takeyama J; Nakamura J; Kimura K; Yoshihama M; Harada N; Ito K; Konno R; Sato S; Okamura K; Sasano H
J Clin Endocrinol Metab; 2001 Jul; 86(7):3436-43. PubMed ID: 11443221
[TBL] [Abstract][Full Text] [Related]
17. Compartmentalization of type I 17 beta-hydroxysteroid oxidoreductase in the human ovary.
Sawetawan C; Milewich L; Word RA; Carr BR; Rainey WE
Mol Cell Endocrinol; 1994 Mar; 99(2):161-8. PubMed ID: 8206323
[TBL] [Abstract][Full Text] [Related]
18. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.
Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638
[TBL] [Abstract][Full Text] [Related]
19. Localization of type 8 17beta-hydroxysteroid dehydrogenase mRNA in mouse tissues as studied by in situ hybridization.
Pelletier G; Luu-The V; Li S; Labrie F
J Histochem Cytochem; 2005 Oct; 53(10):1257-71. PubMed ID: 15923359
[TBL] [Abstract][Full Text] [Related]
20. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]